Aboet A, 2008, Radang Telinga Tengah Menahun, Pidato Pengukuhan Jabatan Guru Besar Tetap Bidang Ilmu Kesehatan Telinga Hidung Tenggorok Bedah Kepala Leher, Universitas Sumatera Utara, USU e-Repository, Medan.
Ahmed M, Mohammed S, 2011. Metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients. Indian Journal Pathology & Microbiology, 54(1); p. 7-14.
Akyıldız I, Take G, Uygur K, Kızıl Y, Aydil U, 2013. Bacterial Biofilm Formation in the Middle-Ear Mucosa of Chronic Otitis Media Patients. Indian J Otolaryngol Head Neck Surg, 65 (Suppl 3):p.557–61.
Albino A, Kimmelman C, Parisier S, 1998. Cholesteatoma: a molecular and cellular puzzle. Am J Otol.19(1):p.7-19.
Alves AL, Ribeiro F, 2004. The role of cytokines in acquired middle ear cholesteatoma: literature review. Rev Bras Otorrinolaringol. V.70, n.6, p.813-8.
Alves A, Barbosa S, Pereira, Carvalho M, Fregnani J, Ribeiro F, 2012. EGFR expression in acquired middle ear cholesteatoma in children and adults. Eur J Pediatr. 171:p.307–10.
Amalinei C, Caruntu I, Balan R, 2007. Biology of metalloproteinases. Romanian Journal of Morphology and Embryology, 48(4):p.323–34. Aquino, Filho, NAC & Aquino, 2011. Epidemiology of Middle Ear and
Mastoid Cholesteatomas, Study of 1146 cases, Brazillian Journal of Otorhinolaryngology, vol.77,no3, May-June, p.1-11.
Aruan SY, 2014. Tesis Spesialis, Hubungan ekspresi tumor necrosis factor alpha (TNF-α) dengan derajat destruksi tulang akibat kolesteatoma pada penderita otitis media supuratif kronis tipe bahaya.
Baig M, Ajmal M, Saeed I, Fatima S, 2011, Prevalence of Cholesteatoma and its Complication in Patients of Chronic Suppurative Otitis Media, Journal of Rawalpindi Medical College (JRMC), vol 15, p.16-17. Bode W, Catalan C, Tschesche H, Grms F, Nagase H, Maskos K, 1999.
Structural properties of matrix metalloproteinases. CMLS Cellular and Molecular Life Sciences. 55, p.639-52.
Browning G, Merchant S, Kelly, G, Swan I, Canter, R, McKerrow W, 2008.`Chronic Otitis Media`, in: Scott-Brown`s Otorhinolaryngology, Head and Neck Surgery, Edward Arnold Ltd, London, p.3395-442. Chen P, Shih Y, Huang H, Cheng H, 2011. Diosgenin, a Steroidal
Saponin, Inhibits Migration and Invasion of Human Prostate Cancer PC-3 Cells by Reducing Matrix Metalloproteinases Expression. PlosOne 6(5) :p.1-9.
Chole R, Nason R, 2009, Chronic Otitis Media and Cholesteatoma, in Ballenger’s Otorhinolaryngoligy Head and Neck Surgery, BC Becker Inc, Shelton Connecticut, USA, p.217-38.
Chole, RA & Sudhoff, HH 2005, `Chronic otitis media, mastoiditis, and petrositis`, dalam CW Cummings et al. (eds), Otolaryngology: Head & Neck Surgery, Mosby, Inc, Philadelphia.
Deb T, Ray D, 2012. A Study of Bacteriological Profile of Chronic Suppurative Otitis Media in Agartala. Indian Journal of Otolaryngology Head and Neck Surg. 64(4); p. 326-9.
Decock J, Hendrickx W, Vanleeuw U, Belle V, Huffel S, Christiaens, M, Ye S, Paridaens R, 2008. Plasma MMP I and MMP 8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis. BMC Cancer, 8:77, p.1-8.
Dhingra PL, 2014, Cholesteatoma and Chronic Suppurative Otitis Media, in Disease of Ear Nose and Throat, sixth Edition, Elsevier, p.66-73. Djaafar ZA, Helmi, Restuti R, 2007. Kelainan Telinga Tengah, Dalam:
Edward Y, Mulyani S, Triansyah I, 2013. Profil Pasien OMSK di Bagian THT-KL RSUP DR. M. Djamil Padang Periode 1 Januari 2010-31 Desember 2012. Kumpulan Naskah Ilmiah KONAS XVI PERHATI-KL Medan, p.190-7.
Frickmann H, Zautner A, 2012, Cholesteatoma – A Potential Consequence of Chronic Middle Ear Inflammation, Review Article, Germany, p.1-8. Fukuda T, Takahashi H, Koji T, 2011. Animal Models of Middle Ear
Cholesteatoma. Review Article, Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology,p.1-11.
Gacek, R 2009, `Anatomy of the auditory and vestibular system`, dalam JB Snow & PA Wackyym (eds), Ballenger’s Otorhinolaryngology Head And Neck Surgery, BC Decker inc, Connecticut.
Gailardin, L. Lescana, S., Moriniere, J., Cottier, A., Robier, A. 2012. Residual cholesteatoma : Prevalence and Location. Follow up Strategy in Adults. Otolaryngology Pol. Vol 12. p.132-6
Ghanie A, 2013. Otitis Media Supuratif Kronik Dengan Komplikasi Intrakranial di RSUP Dr. Mohammad Hoesin. Kumpulan Naskah Ilmiah KONAS XVI PERHATI-KL Medan, p.144-51.
Gulya A, Anatomy of the ear and temporal bone. In: Glasscock-Shambaugh Surgery of the Ear. Fifth edition, BC Decker Inc, Spain: p.35-57.
Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura Y, Kojima T, Iwata N, Ahmed AR, Dahy K, Kondo N, Suzuki K, 2016. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives, Clinical and Experimental Otolaryngology, Korean Society of Otolaryngology-Head and Neck Surgery, p.1-11.
Hardjolukito & Endang, SR 2005, ′The 8th Course and Workshop, Basic
Science In Oncology′, Modul A, Putaran Ke-3, Jakarta.
Helmi. 2005, `Otitis media supuratif kronis`, dalam Otitis Media Supuratif Kronis: Pengetahuan Dasar, Terapi Medik, Mastoidektomi, Timpanoplasti. Balai Penerbit FK-UI, Jakarta.
Islam, R, Taous, A, Hossain, M, Ekramuddaula, Islam M, 2010, ′Comparative Study of Tubotympanic and Atticoantral Variety of Chronic Suppurative Otitis Media′, Bangladesh Journal Otolaryngology, Vol 16, no. 2, p.113-9.
Jesionek D, Szyman´ski M, Kurzepa J, GołEbek W, Stryjecka-Zimmer M, 2008. Gelatinolytic Activity of Matrix Metalloproteinases 2 and 9 in Middle Ear Cholesteatoma. Journal of Otolaryngology-Head & Neck Surgery, Vol 37, No 4; p.1-6.
Juhn S, Jung M, Hoffman M, Drew B, Preciado D, Sausen N, Timothy, Jung K, Kim B, Park S, Lin J, Ondrey F, Mains D, Huang T, 2008, The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae, Clinical and Experimental Otorhinolaryngology, Vol 1, No.3, USA, p.117-38.
Jung JY, Chole R, 2002. Bone resorption in Chronic Otitis Media: The role of Osteoclast. Journal for Oto - Rhino - Laryngology and Its Related Specialties; 64, 2; p.95-107.
Juha´sz A, Sziklai I, Ra´kosy Z, Ecsedi S, A´ da´ny R, Bala´zs M, 2009. Elevated Level of Tenascin and Matrix Metalloproteinase 9 Correlates With the Bone Destruction Capacity of Cholesteatomas. Otology & Neurotology 30:p.559-65
Karnik P, Matta I, Chhapola I, 2011; Etiopathology of acquired cholesteatoma, Review Article, Department of ENT, Mumbai Port Trust Hospital, Wadala (E), Mumbai, Maharashtra, India, Vol 17, Issue 2, p.54-57.
Khasigov P, Podobed O, Ktzoeva S, Gatagonova T, Gracher S, Shiskin S, Berezov T, 2001. Matrix Metalloproteinases of Normal Human Tissue. Biochemistry (Moscow) Vol.6 No.2. p.130-40.
Kuczkowski J, Sakowicz-Burkiewicz, M, Iżycka-Świeszewska E,
factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis. ORL J Otorhinolaryngol Relat Spec, vol. 73, no.2, p.93-9
Kumar S, Aqil S, Dahar A, 2011. Clinical Markers of Cholesteatoma, Journal of Otorhinolaryngology’, vol.09, no.03, pp.138-40.
Lee KJ, 2008, Infections of the Ear, in Essential Otolaryngology Head & Neck Surgery, Ninth Edition, The McGraw-Hill, USA, p.304-40.
Maru N, Pop FL, 2006, Morphological Considerations about Middle Ear Cholesteatoma, Original Article, Romanian Journal of Morphology and Embriology, 47(1), Romania, p.73-77.
Maniu A, Harabagiu O, Schrepler M, Catana A, Fanuta B, Mogianta C, 2014, Molecular Biology Of Cholesteatoma, Romanian Journal of Morphology and Embriology, 55(1), Romania, p.7-13.
Memon A, Matiullah S, Ahmed Z, Marfani M, 2008, Frequency of Un-Safe Chronic Suppurative Otitis Media in Patients with Discharging Ear, Original Article, JLUMHS, p.102-5.
Menner A, 2003. The middle ear, in A Pocket Guide to the Ear. Thieme Stuttgart, New York; p.15-21.
Meyer T, Strunk C, Lambert P, 2014, Cholesteatoma, in Bailey Otolaryngology Head & Neck Surgery, 4th Edition, Lippincott William& Wilkins, p.2433-46.
Morales D, Penido N, da Silva I, Stávale J, Guilherme A, Fukuda Y, 2007. Matrix Metalloproteinase 2: an important genetic marker for cholesteatomas. Rev Bras Otorrinolaringol ;73(1):55-61.
Ningsih M, 2015. Tesis spesialis. Hubungan Ekspresi Interleukin-1 dengan derajat destruksi tulang akibat kolesteatoma pada penderita Otitis media supuratif kronik tipe bahaya.
Novita CE, 2014. Hubungan ekspresi Ki-67 dengan derajat destruksi tulang akibat kolesteatoma pada penderita otitis media supuratif kronis tipe bahaya.
Nukarinen E, Lindström O, Kuuliala K, Kylänpää L, Pettilä V, Puolakkainen P, Kuuliala A, Hämäläinen M, Moilanen E, Repo H, Hästbacka J, 2016. Association of Matrix Metalloproteinases -7,-8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study, PLOS ONE | DOI:10.1371/journal.pone.0161480. p.1-11.
Olszewska E, Matulka M, Mroczko B, Pryczynicz A, Kemona A, zmitkowski M, Mierzwinski J Pietrewicz T, 2016. Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma. Histol Histopathol 31: 307-15 Persaud R, Hajioff D, 2007. Evidence –based Review of Aethiopathogenic
theories of Congenital and Acquired Cholesteatoma. Journal of Laryngology & Otology. p.1013-9.
Poe D, Gopen Q, 2009, Eusthacian Tube Dysfunction, in Ballenger’s Otorhinolaryngology Head and neck Surgery, BC Decker Inc,
Connecticut, p.201-8.
Popescu C, Ionita E, Mogoantă CA, Simionescu C, Pătru E, 2009. Clinical and histopathological aspects in otomastoiditis. Romanian Journal of Morphology and Embryology, 50(3):453–60.
Rezende CE, doSouto R, Rapoport P, de Campos L, Generato M, 2012.Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.Braz J Otorhinolaryngol;78(3);p.116-21.
Rout M, Mohanty D, Vijaylaxmi Y, Kamalesh B, Chakradhar M, 2012; Prevalence of cholesteatoma in CSOM with central perforation, Original Article, Indian Journal of Otology, 18(1), p.7-10.
Schmidt M, Grunsfelder P, Hoppe F, 2001. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma–correlations with growth factor expression in vivo?, Eur Arch Otorhinolaryngol (2001) 258 :p.472–76.
Siregar, DR 2013, Tesis FK USU, ′Profil Penderita Otitis Media Supuratif Kronis (OMSK) Tipe Bahaya di RSUP. H. Adam Malik Medan Tahun 2006 –2010.
Son E, Young D, Quinn F, Quinn M, 2013. Cholesteatoma, an Overview. Grand Rounds Presentation, Department of Otolaryngology – Head and Neck Surgery The University of Texas Medical Branch (UTMB) Health;1-9.
Srivastava A, Singh RK, Varshney S, Gupta P, Bist SS, Bhagat S, Gupta N. 2010. Microbiological Evaluation of an active Tubotympanic Type of Chronic Suppurative Otitis Media. Nepalese Journal of ENT Head & Neck Surgery. Vol. 1(2).
Stark AM, Anuszkiewicz B, Mentlein R, Yoneda T, H Mehdorn HM, Held-Feindt J, 2007 Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231breast cancer cells, J Neurooncol, 81:p.39–48.
Sudhoff H, Dazert S, Gonzales A, Borkowski G, Park S, Baird A, Hildmann H, Ryan A, 2000, Angiogenesis and Angiogenic Growth Factors in Middle Ear Cholesteatoma, The American Journal of Otology, California, U.S.A. p.793–98.
Sudiana, I & Ketut 2005, ′Teknologi Ilmu Jaringan dan Imunohistokimia′, Sagung Seto, Jakarta.
Suryanti D, Rukmini, 2003. Abstrak, ′Otitis media supuratif kronik di Poli THT RS Soetomo Surabaya tahun 2002′, dalam Kongres Nasional XIII PERHATI-KL, Bali.
Thornton D, Martin T, Amin P, Haque S, Wilson S, Smith M, 2011. Chronic suppurative otitis media in Nepal: ethnicity does not determine wether disease is associated with cholesteatoma or not. The Journal of Laryngology & Otology 125,p. 22-6.
World Health Organization 2004, Chronic Suppurative Otitis Media. Burden of Illness and Management Options Geneva, WHO, Switzerland.
Wright T, Valentine P, 2008, The Anatomy and Embriology of the External and Middle Ear, in Scott-Brown’s Otorhinolaryngology Head and Neck Surgery, Volume 3, p.3105-25.
Vasala K, 2008. Matrix metalloproteinase MMP-2 and MMP-9 and their Inhibitors TIMP-1 and TIMP-2 In bladder carcinoma. Acta Universitatis Ouluensis, University press : 22-53.
Verhoeff M, Van der veen E, Rovers M, Sanders E, Schilder A, 2006. Chronic Suppuratice Otitis Media; A Review, International Journal of Pediatric Otorhinolaryngology, 70; p.1-12.
Verma R, Hansch C, 2007. Matrix metalloproteinases (MMPs): Chemical– biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry 15 (2007), Elsevier, p.2223–68.
Yarisman L, 2015. Tesis Spesialis, Hubungan Ekspresi RANKL Terhadap deraJat Destruksi Tulang Pada Penderita OMSK tipe Bahaya di RSUP H. Adam malik Medan.
Yates, PD & Anari, S 2008, `Otitis media`, dalam AK Lalwani (ed), Current Otolaryngology, The McGraw-Hill Companies, New York.
Yoshizaki T, Sato H, Furukawa M, Pagano J, 1998. The expression of matrix metalloproteinase 9 is enhanced by Epstein–Barr virus latent membrane protein 1. Proc Natl Acad Sci USA, 95 : 3621-6.
Yousuf M, Majumder K, Kamal A, Shumon A, Zaman Y, 2011; Clinical Study on Chronic Suppurative Otitis Media with Cholesteatoma, Bangladesh Journal of Otorhinolaryngol, Vol 17, p.42-47.
Zarandy M, Rutka J, 2010. Cholesteatoma and its complications, in: Diseases of the Inner Ear. Springer-Verlag Berlin Heidelberg; p.9-17. Zhu W, Xie Y, Wang P, 2001. Expression of matrix metalloproteinase 2,9
